...
search icon
cai-img

Caris Life Sciences, Inc., Common Stock

CAI

NSQ

$26.54

-$0.18

(-0.67%)

1D

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$7.45B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
0
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$25.56 L
$30.7 H
$26.54

About Caris Life Sciences, Inc., Common Stock

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas. more

Returns

Data is not properly formatted.

Financials

Dec '19Dec '20Dec '22Dec '23Dec '245YR TREND
Total Revenue416.54M294.01M258.49M306.13M412.26M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":70.58,"profit":true},{"date":"2022-12-31","value":62.06,"profit":true},{"date":"2023-12-31","value":73.49,"profit":true},{"date":"2024-12-31","value":98.97,"profit":true}]
Cost of Revenue216.03M109.86M178.46M216.82M233.48M[{"date":"2019-12-31","value":92.53,"profit":true},{"date":"2020-12-31","value":47.05,"profit":true},{"date":"2022-12-31","value":76.44,"profit":true},{"date":"2023-12-31","value":92.86,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit200.51M184.16M80.02M89.31M178.78M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":91.84,"profit":true},{"date":"2022-12-31","value":39.91,"profit":true},{"date":"2023-12-31","value":44.54,"profit":true},{"date":"2024-12-31","value":89.16,"profit":true}]
Gross Margin48.14%62.64%30.96%29.17%43.37%[{"date":"2019-12-31","value":76.85,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2022-12-31","value":49.43,"profit":true},{"date":"2023-12-31","value":46.58,"profit":true},{"date":"2024-12-31","value":69.24,"profit":true}]
Operating Expenses70.23M45.07M574.24M625.68M669.38M[{"date":"2019-12-31","value":10.49,"profit":true},{"date":"2020-12-31","value":6.73,"profit":true},{"date":"2022-12-31","value":85.79,"profit":true},{"date":"2023-12-31","value":93.47,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income130.28M139.09M(315.76M)(319.55M)(257.12M)[{"date":"2019-12-31","value":93.67,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-227.02,"profit":false},{"date":"2023-12-31","value":-229.75,"profit":false},{"date":"2024-12-31","value":-184.86,"profit":false}]
Total Non-Operating Income/Expense--(5.07M)(21.86M)(24.77M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-507100000,"profit":false},{"date":"2023-12-31","value":-2186400000,"profit":false},{"date":"2024-12-31","value":-2476800000,"profit":false}]
Pre-Tax Income55.21M82.24M(320.83M)(341.42M)(281.89M)[{"date":"2019-12-31","value":67.13,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-390.1,"profit":false},{"date":"2023-12-31","value":-415.13,"profit":false},{"date":"2024-12-31","value":-342.76,"profit":false}]
Income Taxes4.19M1.80M---[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":42.94,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations--(320.83M)(341.42M)(281.89M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-32082700000,"profit":false},{"date":"2023-12-31","value":-34141500000,"profit":false},{"date":"2024-12-31","value":-28189000000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income31.01M27.73M(320.83M)(341.42M)(281.89M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":89.43,"profit":true},{"date":"2022-12-31","value":-1034.56,"profit":false},{"date":"2023-12-31","value":-1100.95,"profit":false},{"date":"2024-12-31","value":-909,"profit":false}]
EPS (Diluted)-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CAI
Current Ratio 1.05
Quick Ratio 0.83

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CAI
ROA (LTM) 0.00%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CAI
Debt Ratio Lower is generally better. Negative is bad. 9.92
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -8.92

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CAI
Trailing PE NM
Forward PE NM
P/S (TTM) 17.55
P/B 0.00
Price/FCF NM
EV/R 18.40
EV/Ebitda NM

FAQs

What is Caris Life Sciences, Inc. share price today?

Caris Life Sciences, Inc. (CAI) share price today is $26.54

Can Indians buy Caris Life Sciences, Inc. shares?

Yes, Indians can buy shares of Caris Life Sciences, Inc. (CAI) on Vested. To buy Caris Life Sciences, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CAI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Caris Life Sciences, Inc. be purchased?

Yes, you can purchase fractional shares of Caris Life Sciences, Inc. (CAI) via the Vested app. You can start investing in Caris Life Sciences, Inc. (CAI) with a minimum investment of $1.

How to invest in Caris Life Sciences, Inc. shares from India?

You can invest in shares of Caris Life Sciences, Inc. (CAI) via Vested in three simple steps:

  • Click on Sign Up or Invest in CAI stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Caris Life Sciences, Inc. shares
What is Caris Life Sciences, Inc. 52-week high and low stock price?

The 52-week high price of Caris Life Sciences, Inc. (CAI) is $30.7. The 52-week low price of Caris Life Sciences, Inc. (CAI) is $25.56.

What is Caris Life Sciences, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Caris Life Sciences, Inc. (CAI) is 0.00

What is the Market Cap of Caris Life Sciences, Inc.?

The market capitalization of Caris Life Sciences, Inc. (CAI) is $7.45B

What is Caris Life Sciences, Inc.’s stock symbol?

The stock symbol (or ticker) of Caris Life Sciences, Inc. is CAI

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top